ABSTRACT
Patients with esophageal achalasia, treated by pneumocardiodilatation with "Esophageal balloon dilatation" of the firm "Cook"--Denmark with a size of 22 mm in an inflamed state, were followed up for a period of 8 years. The result of the first course of pneumocardiodilatation treatment was unsatisfactory in 13.9% of the patients and they were recommended a surgical treatment. In the remaining patients the duration of the treatment effect lasted from 10 months up to 8 years. In 16.1% of the patients repeated redilatations were needed at intervals of 10 to 22 months. For this group of patients a decision should be made how to proceed further--with repeated pneumocardiodilatations or with surgical treatment.
Subject(s)
Catheterization/methods , Esophageal Achalasia/therapy , Adolescent , Adult , Aged , Catheterization/instrumentation , Child , Esophageal Achalasia/epidemiology , Female , Follow-Up Studies , Humans , Male , Middle Aged , Remission InductionABSTRACT
The glycoproteins (GP) of 329 patients with liver diseases and 60 clinically healthy subjects were complexly studied: sialic acid, orozomucoid, haptoglobin, ceruloplasmin, cholinesterase, hexosamine and fucose. Modern laparoscopic, bioscopic, histochemical and histomorphological methods were used in making the diagnosis and determination of the disease phase; The liver diseases are characterized by quantitative and qualitative differences in the character of the GP changes in serum. GP are mostly changed in acute viral hepatitis, cirrhosis, extrahepatic cholestasis and liver tumours, less in chronic aggressive hepatitis and no change in chronic persistent hepatitis and steatosis. The complex GP study is of significance in the characteristic of the activity of the pathological process, in the specification of the liver function as well as for the prognosis of a certain disease.
